HIMS & HERS HEALTH INC (HIMS)

US4330001060 - Common Stock

26.2  -0.16 (-0.61%)

After market: 26.38 +0.18 (+0.69%)

HIMS & HERS HEALTH INC

NYSE:HIMS (12/20/2024, 8:16:42 PM)

After market: 26.38 +0.18 (+0.69%)

26.2

-0.16 (-0.61%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS SubIndustryHealth Care Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%900%
Sales Q2Q%77.13%
CRS98.06
6 Month18.28%
Overview
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Ins Owners11.56%
Inst Owners65.92%
Market Cap5.72B
Shares218.48M
PE59.55
Fwd PE51.65
Dividend YieldN/A
Analysts72
Short Float %23.11%
Short Ratio2.38
IPO09-09 2019-09-09
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

HIMS Daily chart

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,046 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. The company offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. The company offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

Company Info

HIMS & HERS HEALTH INC

2269 Chestnut St, #523

San Francisco CALIFORNIA 94123

P: 14158510195

CEO: Andrew Dudum

Employees: 1046

Website: https://www.forhims.com/

HIMS News

News Image2 days ago - The Motley FoolHims & Hers Stock: Growth, Noise, and Where to Focus Now

Hims & Hers stock is full of noise, but what's the signal for investors?

News Image2 days ago - Market News VideoNoteworthy Thursday Option Activity: EXE, OMER, HIMS
News Image2 days ago - Investor's Business DailyIBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List

Compounders now have until late March to wind down their operations, depending on their licensing.

ChartMill News Image3 days ago - ChartmillIs NYSE:HIMS suited for growth investing?

HIMS & HERS HEALTH INC (NYSE:HIMS) may be suited for growth investing, we'll explore why in this article.

News Image3 days ago - The Motley FoolThis Is Huge News for Eli Lilly Investors

Eli Lilly just gave investors several reasons to cheer.

News Image4 days ago - Market News VideoTop Buys by Directors: Manuel's $132.3K Bet on HIMS

HIMS Twits

Here you can normally see the latest stock twits on HIMS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example